SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $7,995,000 | +35.0% | 81,971 | +28.4% | 0.02% | +26.7% |
| Q4 2014 | $5,924,000 | +31.4% | 63,848 | -2.6% | 0.02% | +36.4% |
| Q3 2014 | $4,508,000 | -19.4% | 65,548 | +22.9% | 0.01% | -21.4% |
| Q2 2014 | $5,590,000 | +11.0% | 53,342 | -12.1% | 0.01% | 0.0% |
| Q1 2014 | $5,034,000 | +24.2% | 60,673 | -3.1% | 0.01% | +16.7% |
| Q4 2013 | $4,052,000 | – | 62,607 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|